Stockscreener 앱 받기
0.7739
9.15%
0.0649
시간 외 거래:
.77
-0.0039
-0.50%
전일 마감가:
$0.709
열려 있는:
$0.71
하루 거래량:
95,786
Relative Volume:
0.16
시가총액:
$19.26M
수익:
$522.00K
순이익/손실:
$-10.80M
주가수익비율:
-1.3473
EPS:
-0.5744
순현금흐름:
$-8.78M
1주 성능:
+7.71%
1개월 성능:
+16.90%
6개월 성능:
-24.86%
1년 성능:
-43.92%
1일 변동 폭
$0.6779
$0.7825
1주일 범위
$0.6349
$0.7825
52주 변동 폭
$0.46
$1.8955
Lexaria Bioscience Corp Stock (LEXX) Company Profile
명칭
Lexaria Bioscience Corp
전화
250-765-6424
주소
100 - 740 MCCURDY ROAD, KELOWNA
Compare LEXX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.7739 | 17.65M | 522.00K | -10.80M | -8.78M | -0.5744 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Lexaria Bioscience Corp 주식(LEXX)의 최신 뉴스
Lexaria launches 2026 research program for drug delivery tech - Investing.com Nigeria
Lexaria launches 2026 research program for drug delivery tech By Investing.com - Investing.com Australia
Lexaria Announces New R&D Plans for 2026 - Investing News Network
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery - TipRanks
LEXX Initiates 2026 R&D Program to Enhance Pharma Innovations - GuruFocus
Biotech tests new oral GLP-1 formulas against Wegovy tablets - Stock Titan
Update Recap: Will Smith Douglas Homes Corp benefit from rate cuts2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
Is Lexaria Bioscience Corp. exposed to currency risksMarket Performance Recap & Technical Pattern Alert System - mfd.ru
Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability - The Globe and Mail
Aug Wrap: Is Lexaria Bioscience Corp a strong candidate for buy and holdEarnings Recap Summary & Weekly High Potential Stock Alerts - baoquankhu1.vn
Lexaria Bioscience: Oral Drug Delivery Technology Targets Next-Gen Weight Loss Market - The Globe and Mail
LEXX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
LEXX Should I Buy - Intellectia AI
Aug Intraday: Can Lexaria Bioscience Corp expand into new marketsJuly 2025 Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn
US Market Wrap: What are the risks of holding Hanover Bancorp IncMarket Growth Summary & Safe Capital Allocation Plans - baoquankhu1.vn
Update Report: Can Lexaria Bioscience Corp Equity Warrant sustain earnings growth2025 Dividend Review & Low Risk Investment Opportunities - baoquankhu1.vn
Published on: 2026-02-20 23:25:19 - baoquankhu1.vn
Will Lexaria Bioscience Corp. Equity Warrant stock go up in YEARJuly 2025 Selloffs & Entry Point Confirmation Signals - mfd.ru
Published on: 2026-02-20 04:22:15 - baoquankhu1.vn
Aug Intraday: Is Lexaria Bioscience Corp exposed to currency risksJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Aug Action: Will NHICU outperform tech stocksDip Buying & Verified Short-Term Trading Plans - baoquankhu1.vn
Is Lexaria Bioscience Corp. likely to announce a buyback2025 Support & Resistance & Entry Point Strategy Guides - mfd.ru
How Lexaria Bioscience Corp. Equity Warrant stock performs in interest rate cyclesQuarterly Earnings Summary & AI Optimized Trade Strategies - mfd.ru
Why Lexaria Bioscience Corp. stock could rally in 2025July 2025 Update & Real-Time Market Trend Scan - mfd.ru
Can Lexaria Bioscience Corp. ride the EV wave2025 AllTime Highs & AI Powered Market Entry Strategies - mfd.ru
Will Lexaria Bioscience Corp. stock attract ESG investorsMarket Trend Report & Entry and Exit Point Strategies - mfd.ru
LEXX PE Ratio & Valuation, Is LEXX Overvalued - Intellectia AI
Aug Momentum: Can Lexaria Bioscience Corp. Equity Warrant stock outperform in 2025 bull marketWatch List & AI Optimized Trading Strategy Guides - mfd.ru
Can Lexaria Bioscience Corp. Equity Warrant sustain earnings growthJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - mfd.ru
Research Analysts Set Expectations for LEXX Q2 Earnings - Defense World
Analysts Set Expectations for LEXX FY2028 Earnings - Defense World
Is Lexaria Bioscience Corp. Equity Warrant exposed to political riskRecession Risk & AI Driven Stock Price Forecasts - mfd.ru
Quarterly Earnings: Is Lexaria Bioscience Corp a strong candidate for buy and holdMarket Growth Summary & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Lexaria Bioscience Stock Price, News, Quote & History - Investing News Network
Bear Alert: Can Lexaria Bioscience Corp expand into new markets2025 Market WrapUp & Weekly Top Gainers Trade List - baoquankhu1.vn
Aug Swings: What is Lexaria Bioscience Corp Equity Warrants revenue forecastJuly 2025 Spike Watch & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Hedge Fund Moves: Does Lexaria Bioscience Corp have declining or rising EPSWeekly Stock Recap & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Lexaria Bioscience Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study - TipRanks
Lexaria Bioscience (LEXX) Demonstrates Promising Results in Late - GuruFocus
Lexaria Announces Positive Final Results from Human Pilot Study #5 - Investing News Network
Lexaria Announces Positive Final Results From Human Pilot Study #5 - The Joplin Globe
Experimental liraglutide pill shows similar results, 67% less nausea - Stock Titan
Signal Recap: Does Lexaria Bioscience Corp offer margin of safetyPortfolio Return Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
Aug Outlook: What is Lexaria Bioscience Corp. Equity Warrant s revenue forecastBreakout Watch & Fast Gaining Stock Reports - baoquankhu1.vn
Aug Levels: Can Lexaria Bioscience Corp sustain its profitabilityJuly 2025 Reactions & Accurate Entry/Exit Alerts - baoquankhu1.vn
Jobs Data: Will Lexaria Bioscience Corp Equity Warrant stock go up in YEAR2025 Growth vs Value & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Portfolio Recap: Is Lexaria Bioscience Corp Equity Warrant currently under institutional pressureJuly 2025 Volume & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Sectors: Is Lexaria Bioscience Corp exposed to political riskWeekly Trading Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Lexaria Bioscience Corp (LEXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):